Entera Bio Ltd.
ENTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $79,818 | $17,405 | $21,030 | $73,697 |
| - Cash | $8,660 | $11,019 | $12,309 | $24,892 |
| + Debt | $272 | $390 | $91 | $302 |
| Enterprise Value | $71,430 | $6,776 | $8,812 | $49,107 |
| Revenue | $181 | $0 | $134 | $571 |
| % Growth | – | -100% | -76.5% | – |
| Gross Profit | $9 | -$56 | -$31 | $198 |
| % Margin | 5% | – | -23.1% | 34.7% |
| EBITDA | -$9,539 | -$8,804 | -$12,870 | -$12,164 |
| % Margin | -5,270.2% | – | -9,604.5% | -2,130.3% |
| Net Income | -$9,541 | -$8,889 | -$13,071 | -$12,187 |
| % Margin | -5,271.3% | – | -9,754.5% | -2,134.3% |
| EPS Diluted | -0.25 | -0.31 | -0.45 | -0.47 |
| % Growth | 19.4% | 31.1% | 4.3% | – |
| Operating Cash Flow | -$6,818 | -$7,310 | -$12,499 | -$9,063 |
| Capital Expenditures | -$3 | -$17 | -$47 | -$17 |
| Free Cash Flow | -$6,821 | -$7,327 | -$12,546 | -$9,080 |